title: [Registration study on analysis of adaptation syndromes and medication characteristics of tanreqing injection].
abstract: Tanreqing injection is suitable for early pneumonia, acute bronchitis, acute exacerbations of chronic, and upper respiratory tract infection which are classified with phlegm-heat obstructing lung syndrome of traditional Chinese medicine. To understand the clinical adaptation syndromes and medication characteristics of the post-market Tanreqing injection, the research team of the paper monitored the patients who are used with Tanreqing injection from September 2012 to October 2013 in four leader hospitals based on the method--prospective, multi-center, large sample, registration-type hospital centralized monitoring,and analyzes the general information, diagnostic information and medication characteristics of patients, in order to produce evidence for clinical practice and medication decisions and to establish the foundation of rational drug use.
authors.forename: Peng-Yang
authors.initials: PY
authors.lastname: Xie
authors.forename: Yan-Ming
authors.initials: YM
authors.lastname: Xie
authors.forename: Lian-Xin
authors.initials: LX
authors.lastname: Wang
authors.forename: Yan-Peng
authors.initials: YP
authors.lastname: Chang
authors.forename: Li
authors.initials: L
authors.lastname: You
authors.forename: Xiao-Li
authors.initials: XL
authors.lastname: Zhang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008516:Medicine, Chinese Traditional; D008875:Middle Aged; D011446:Prospective Studies; D012141:Respiratory Tract Infections; D055815:Young Adult
chemical_list: D004365:Drugs, Chinese Herbal; C540817:tanreqing